Nalaganje...

Metyrapone in treatment-resistant depression

Depression affects a significant proportion of the population, with 1-year and lifetime prevalence of 3–5% and 10–30% respectively. Full remission is achieved in only a third of patients following treatment with first-line antidepressant. There is a need for novel treatments for treatment-resistant...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Sigalas, Paul David, Garg, Himanshu, Watson, Stuart, McAllister-Williams, Richard Hamish, Ferrier, I. Nicol
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2012
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3736936/
https://ncbi.nlm.nih.gov/pubmed/23983967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125312436597
Oznake: Označite
Brez oznak, prvi označite!